Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.

Int J Nanomedicine · 2013 · PMC3746731 · PMID 23976850

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP < 0.0001actually significant

Although the above particle size difference was insignificant ( P > 0.07; n = 6), the mean zeta potential difference was highly significant ( P < 0.0001; n = 6).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.